Ovarian Cancer Research Alliance announced this week that the organization will join forces with The Clearity Foundation in January 2025. This development, which promises to further strengthen OCRA’s services for the ovarian cancer and gynecologic cancer community, was covered in the September 27, 2024 publication of The Chronicle of Philanthropy.
The Clearity Foundation Joins The OCRA Family A Special Message from OCRA’s President & CEO Dear OCRA Community, Earlier this week, we shared some exciting news as we close out Ovarian Cancer and Gynecologic Cancer Awareness Month. OCRA is joining forces with The Clearity Foundation, further strengthening our commitment to supporting the ovarian and entire … Continued
OCRA to Expand Its Patient Support by Integrating Clearity’s Pioneering Programs. NEW YORK, NY, September 24, 2024 – Ovarian Cancer Research Alliance (OCRA), the world’s largest ovarian cancer nonprofit, is proud to announce that The Clearity Foundation will combine with OCRA, effective January 1, 2025. This important development brings together two of the most respected organizations in the ovarian cancer field, combining OCRA’s leading … Continued
A new piece published September 6, 2024, on Yahoo! News, is highlighting the impact of Ovarian Cancer Research Alliance’s annual Ovarian Cycle Tampa event. “Ovarian cancer survivors and supporters Cycle for the Cause”spotlights the efforts of participants and event organizers, and features on-site reporting from WFTS-TV ABC Action News Tampa Bay. Read the full piece … Continued
OCRA’s Ovarian Cycle Tampa marked its 12th year of raising funds and awareness for ovarian cancer research this past weekend, as reported by WFTS-TV ABC Action News Tampa Bay’s Robert Boyd. The event took place on September 7th, with an indoor cycling ride at Union Three. “It’s gratifying to me that other people who have … Continued
Harper’s Bazaar has published a powerful new piece by Chris Tilberis, who serves on OCRA’s Board of Directors, reflecting on his mother Liz Tilberis’ remarkable career as the former editor-in-chief of Harper’s Bazaar, president of OCRA and her legacy in the fight against ovarian cancer. “I think she felt that talking about things—even very difficult … Continued
As Ovarian and Gynecologic Cancer Awareness Month begins, Ovarian Cancer Research Alliance (OCRA) is proud to highlight a series of initiatives aimed at expanding access and promoting equity in ovarian and all gynecologic cancer care. This year’s efforts include the launch of targeted research grants to address health inequities, a new “Find a Doctor” tool to … Continued
Help OCRA Make an Impact for Ovarian Cancer and Gynecologic Cancer Awareness Month September is Ovarian Cancer Awareness Month and Gynecologic Cancer Awareness Month. As the largest non-profit in the world combating ovarian and gynecologic cancers, OCRA is committing to raise $300,000 this September to accelerate progress in research, advocate for our community, and continue … Continued
Fortune Magazine Shares OCRA’s Lifesaving Ovarian Cancer Prevention Message In light of Chris Evert’s ovarian cancer diagnosis, OCRA’s Chief Program Officer, Sarah DeFeo, and OCRA’s Scientific Advisory Committee member Dr. Gillian Hanley, spoke with Fortune Magazine about why knowing one’s risk and taking preventative action, such as fallopian tube removal at the time of planned … Continued
In an article titled “Amazon MGM Studios’ Debra Birnbaum Joins Ovarian Cancer Research Alliance Board,” Variety editor William Earl writes about MGM Studios’ Debra Birnbaum’s appointment to Ovarian Cancer Research Alliance’s board of directors. An ovarian cancer survivor, Debra Birnbaum talks about what inspired her to join OCRA, and what she hopes to accomplish for … Continued
In light of Chris Evert’s ovarian cancer diagnosis, OCRA’s Chief Program Officer, Sarah DeFeo, spoke with Fortune Magazine about why knowing risk and taking preventative action can save lives, and about OCRA’s free genetic testing kit program for those at increased risk. Read the article, “With ovarian cancer, there’s no such thing as early detection. … Continued
Amazon MGM Studios’ Debra Birnbaum, Media Visionary & Ovarian Cancer Survivor, Joins OCRA Board of Directors Ovarian Cancer Research Alliance is proud to announce that Debra Birnbaum has joined its Board of Directors. Birnbaum is an accomplished multi-platform content creator and media strategist with over 20 years of experience covering news and entertainment, and the current global … Continued
Get email updates about research news, action alerts, and ways to join the fight.
